Corporate Profile / Access

As of Feb. 1, 2024

Mitsubishi Chemical Group Corporation

Company name

Mitsubishi Chemical Group Corporation

Head office

1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8251

View on Google MapsNew tab

Access ・8-minutes walk from the Marunouchi North Exit of JR Tokyo Station
・One-minute walk from Exit C13b of Otemachi Station (subway)
Representative Representative Corporate Executive Officer, President & Chief Executive Officer, Jean-Marc Gilson
Date of establishment October 3, 2005
Paid-in capital 50 billion yen
Main scope of business Management of Group companies
(Development of the Group strategies and allocation of financial resource)
Sales revenue (Consolidated) 4,634.5 billion yen (FY2022)
Number of employees 68,639 (Consolidated) (As of March 31, 2023)
Subsidiaries and affiliates 593 (Consolidated subsidiaries:422 As of March 31, 2023)
Listings The Prime Market of Tokyo Stock Exchange
Fiscal year end March 31

Mitsubishi Chemical Corporation

Company name

Mitsubishi Chemical Corporation

Head office

1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8251

View on Google MapsNew tab

Access ・8-minutes walk from the Marunouchi North Exit of JR Tokyo Station
・One-minute walk from Exit C13b of Otemachi Station (subway)
Representative Representative Director, Kouji Eguchi
Representative Director, Manabu Chikumoto
Date of incorporation April 1, 2017 (Date of foundation: August 31, 1933)
Paid-in capital 53,229 million yen
Line of business Performance products, industrial materials, and others
Number of employees 42,127 (Consolidated), 13,100 (Non-consolidated)  (As of March 31, 2023)
Shareholder Mitsubishi Chemical Group Corporation 100%

Mitsubishi Tanabe Pharma Corporation

Company name

Mitsubishi Tanabe Pharma Corporation

Head office

2-10 Dosho-machi, 3-chome, Chuo-ku, Osaka 541-8505

View on Google MapsNew tab

Access ・8-minutes walk from Exit 11 of Yodoyabashi Station on the Subway Midosuji Line.
・10-minutes walk from Exit 6 of Kitahama Station on Subway Sakaisuji Line.
Representative Representative Director, Akihiro Tsujimura
Representative Director, Hiroaki Ueno
Date of incorporation October 1, 2007
Paid-in capital 50 billion yen
Line of business Manufacture and sale of pharmaceuticals, centered on ethical drugs
Number of employees 6,370 (Consolidated) 3,107 (Non-consolidated)(As of March 31, 2023)
Shareholder Mitsubishi Chemical Group Corporation 100%

Nippon Sanso Holdings Corporation

Company name

Nippon Sanso Holdings Corporation

Head office

Toyo Bldg., 1-3-26 Koyama, Shinagawa-ku Tokyo 142-8558, Japan

View on Google MapsNew tab

Access ・Transit to the Tokyu Meguro Line at the JR Meguro Station and get off at the Fudomae Station.7 minutes’ walk from the Fudomae Station to our head office.
Representative Representative Director, President CEO Toshihiko Hamada
Date of incorporation July 19, 1918(Date of establishment: October 30, 1910)
Paid-in capital 37,344 million yen
Line of business Subsidiary management and group operations in industrial gas
Number of employees Consolidated:19,579 (As of March 31, 2023)
Shareholder Mitsubishi Chemical Group Corporation 50.6%

Life Science Institute, Inc.

Company name Life Science Institute, Inc.
Head office 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8251
Representative Representative Director, Director of the Board, Ryosuke Tanabe
Date of incorporation April 1, 2014
Paid-in capital 10 million yen
Shareholder Mitsubishi Chemical Group Corporation 100%

*Life Science Institute, Inc. closed its website in association with the discontinuation of the development and commercialization of regenerative medicine products using Muse cells.
 News Release (February 14, 2023) https://www.mcgc.com/english/news_release/01489.html

<Contact for inquiries about Life Science Institute , Inc.>
Call center, Mitsubishi Chemical Group Corporation
TEL:+81-(0)3-6748-7200 +81-(0)3-6748-7200
Contact Form

Back to top